Pediatrics. 1984 Dec;74(6):1004-11.
Biopterin synthesis defects: problems in diagnosis.
Hyperphenylalaninemia
due to a biopterin synthesis defect was detected in an infant with
decreased biopterin and increased neopterin levels in plasma and urine.
Tetrahydrobiopterin (BH4) administration normalized plasma phenylalanine levels.
CSF biopterin and neurotransmitter metabolite levels were normal and with the infant's normal growth and development suggest that the defect in biopterin synthesis did not affect CNS biopterin metabolism.
Comparison of plasma and urine pterin levels from this patient with levels reported in patients who have neurologic complications fails to reveal differences that would distinguish patients at risk for neurologic problems. CSF pterin and neurotransmitter levels may correlate with neurologic function in these patients. CSF pterin and neurotransmitter determinations should be performed prior to initiation of neurotransmitter precursor and BH4 replacement therapies in patients who were determined to have biopterin synthesis defect(s).
Tetrahydrobiopterin (BH4) administration normalized plasma phenylalanine levels.
CSF biopterin and neurotransmitter metabolite levels were normal and with the infant's normal growth and development suggest that the defect in biopterin synthesis did not affect CNS biopterin metabolism.
Comparison of plasma and urine pterin levels from this patient with levels reported in patients who have neurologic complications fails to reveal differences that would distinguish patients at risk for neurologic problems. CSF pterin and neurotransmitter levels may correlate with neurologic function in these patients. CSF pterin and neurotransmitter determinations should be performed prior to initiation of neurotransmitter precursor and BH4 replacement therapies in patients who were determined to have biopterin synthesis defect(s).
- PMID:
- 6150460
- [Indexed for MEDLINE]
http://www.sciencedirect.com/topics/neuroscience/biopterin
Ilmeinen kognition kehittyminen essentielleistä tarpeista ihmiskunnalla toimii pohjageneraattorina biopteriinin muodostukselle jollioin tuottuu mm dopa, adrenaliini, noradrenaliini ja kilpirauhashormoneille tärkeä tyrosiinikin paremmin koentsyymin tehostamana.
Tähän generoituun biopteriiniin antaa tehoa foolihappo, koska se voi uudistaa biopteriiin aktiivia muotoa, joka pystyy taas käyttämään happea siten, että ei synny aivoissa superoksidianionia.
Nonnutrients
Martin Kohlmeier, in Nutrient Metabolism (Second Edition), 2015
Regulation
Biopterin
status is predominantly controlled by modulation of GTP cyclohydrolase 1
expression and activity. Gamma-interferon and other cytokines increase biopterin production by inducing GTP cyclohydrolase 1 (Thöny et al., 2000). Glucocorticoids prevent cytokine-mediated induction of GTP cyclohydrolase 1 (Simmons et al., 1996), apparently via a cyclic adenosine monophosphate (cAMP)–-mediated signaling cascade (Ohtsuki et al., 2002). Food deprivation of animals increases biopterin production and concentration in the blood (Koller et al., 1990).
Inflammation and infection tend to depress availability of biopterin in tissues, such as endothelia of small blood vessels, due to rapid oxidation of the reduced form (McNeill and Channon, 2012).
Aminoacidopathies and Organic Acidopathies, Mitochondrial Enzyme Defects, and Other Metabolic Errors
Generoso G. Gascon, ... Bruce Cohen, in Textbook of Clinical Neurology (Third Edition), 2007
PATHOGENESIS AND PATHOPHYSIOLOGY
Defective synthesis of biopterin (BH4)
causes disruption in several biochemical functions.
Deficiencies of the
first two steps, that is, guanosine triphosphate cyclohydrolase
(GTP‐CH) and 6‐pyruvoyltetra‐hydropterin synthase (6PTS), are known as
synthetic defects. The hydroxylase reacts with BH4,
converting it to its hydroxy form 4α‐carbinolamine, which is then
dehydrated by primapterin carbinolamine dehydratase (PCD) to quininoid
dihydrobiopterin, which is labile and must be reduced back to BH4
through a reaction that uses reduced nicotinamide adenine dinucleotide
and is catalyzed by dihydropteridine reductase (DHPR).
The deficiencies
of the latter two enzymes are known as recycling defects. Because
primapterin is excreted in PCD deficiency, the disease is also called
primapterinuria.
BH4 is a cofactor for
enzymes of the initial step in dopamine and serotonin synthesis; when it
is not available, neurotransmitter and autonomic function, both in the
CNS and periphery, are disturbed.
In addition, BH4 is a cofactor for the generation of nitric oxide in the CNS, which is a neurotransmitter/modulator. (verisuonten dilataatiotgekijä, estää verisuonikollapsia)
Deficiency of BH4
causes
- severe autonomic irregularities and
- mental retardation and, ultimately,
- is not compatible with life
- . Severe cardiopulmonary dysrhythmia,
- fluctuating blood pressure,
- sleep irregularities,
- and early unexpected death
may be explained by these considerations.
Because
4α‐carbinolamine can be spontaneously dehydrated, PCD deficiency does
not cause severe disease.
- In BH4‐dependent PKU, neurological manifestations are severe in the presence of mild hyperphenylalaninemia, suggesting that trace BH4 levels are sufficient to promote the phenylalanine hydroxylase reaction in liver but not high enough for adequate hydroxylation of tyrosine and tryptophan in the CNS.
- All four diseases are inherited as autosomal recessive.
- The location of their genes is shown in Table 31‐3.
Inga kommentarer:
Skicka en kommentar